1. Home
  2. ABVX vs CALM Comparison

ABVX vs CALM Comparison

Compare ABVX & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • CALM
  • Stock Information
  • Founded
  • ABVX 2013
  • CALM 1957
  • Country
  • ABVX France
  • CALM United States
  • Employees
  • ABVX N/A
  • CALM N/A
  • Industry
  • ABVX
  • CALM Farming/Seeds/Milling
  • Sector
  • ABVX
  • CALM Consumer Staples
  • Exchange
  • ABVX Nasdaq
  • CALM Nasdaq
  • Market Cap
  • ABVX 6.7B
  • CALM 5.5B
  • IPO Year
  • ABVX N/A
  • CALM 1996
  • Fundamental
  • Price
  • ABVX $90.65
  • CALM $91.80
  • Analyst Decision
  • ABVX Strong Buy
  • CALM Hold
  • Analyst Count
  • ABVX 9
  • CALM 3
  • Target Price
  • ABVX $94.11
  • CALM $103.33
  • AVG Volume (30 Days)
  • ABVX 957.6K
  • CALM 1.3M
  • Earning Date
  • ABVX 08-11-2025
  • CALM 10-01-2025
  • Dividend Yield
  • ABVX N/A
  • CALM 9.13%
  • EPS Growth
  • ABVX N/A
  • CALM 198.25
  • EPS
  • ABVX N/A
  • CALM 26.04
  • Revenue
  • ABVX $7,073,400.00
  • CALM $4,398,616,000.00
  • Revenue This Year
  • ABVX $4.44
  • CALM N/A
  • Revenue Next Year
  • ABVX N/A
  • CALM N/A
  • P/E Ratio
  • ABVX N/A
  • CALM $3.52
  • Revenue Growth
  • ABVX N/A
  • CALM 65.80
  • 52 Week Low
  • ABVX $4.77
  • CALM $79.55
  • 52 Week High
  • ABVX $93.77
  • CALM $126.40
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 74.86
  • CALM 26.12
  • Support Level
  • ABVX $85.00
  • CALM $91.49
  • Resistance Level
  • ABVX $90.70
  • CALM $94.60
  • Average True Range (ATR)
  • ABVX 2.98
  • CALM 3.01
  • MACD
  • ABVX -0.26
  • CALM -0.32
  • Stochastic Oscillator
  • ABVX 75.33
  • CALM 34.12

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

Share on Social Networks: